Generate a tailored SOP for Dr. Murty Vundavalli. Improve your application with a focused, well-structured draft.
Murty Vundavalli is a clinical geneticist specializing in cancer genetics within the Department of Pathology at Columbia University. His expertise encompasses cytogenetic studies, molecular diagnostics, and translational research in hematologic malignancies and cancer genetics. With a commitment to advancing the understanding of the genetic and epigenetic bases of diseases, Dr. Vundavalli has contributed significantly to research focused on cervical cancer and hematologic diseases. His work aims to identify prognostic markers that can enhance treatment response for patients. He has held various editorial positions, including Associate Editor and Executive Editor for 'Molecular Cancer.' Dr. Vundavalli has been an active member of numerous prestigious professional societies and has participated in significant scientific committees, contributing to advancements in cancer research and treatment strategies. His work involves developing predictive biomarkers to stratify patient responses to combination drug therapies, with ongoing preclinical validations of epigenetically inactivated markers. Throughout his career, he has engaged with different facets of genetics research, including the exploration of genetic alterations in early-stage cancer transformations. Dr. Vundavalli's publications can be found on platforms such as PubMed, highlighting his active contribution to the field of cancer genetics.
Columbia University • New York, NY
Instructing and mentoring students in clinical genetics and pathology.
Cancer Cytogenetics • New York, NY
Overseeing cytogenetic studies and research in cancer diagnostics and treatment.
Department of Anthropology (GSAS)